Nobody Bid: A €5.5 Million Cancer-Diagnostics Equipment Tender in Italy Just Closed Without a Single Offer
21 Jul 2026
StandfirstAzienda USL della Romagna set out to rent advanced automated systems for detecting cancer biomarkers in tissue samples, equipment that helps pathologists determine, among other things, which breast cancer patients will respond to specific targeted therapies. The competition for one of its two lots, worth an estimated €5.48 million, closed with zero tenders submitted. Not a low bid. Not a disqualified bid. No bid at all.IntroductionMost stories about failed public tenders involve too much competition driving prices down or bids coming in above budget. This one is different and rarer: a genuinely attractive, multi million euro contract for specialised medical laboratory equipment that attracted no interest whatsoever from a global supplier market that includes some of the best known names in diagnostic pathology.Azienda USL della Romagna, the regional health authority covering Ravenna, Forlì, Cesena, Rimini and the surrounding Romagna area, ran an open, EU wide procedure to rent automated systems for immunohistochemistry testing, the laboratory technique pathologists use to detect specific proteins in tissue samples, a process central to diagnosing and classifying many cancers. The tender was split into two lots. This notice concerns the first: a three year rental contract for systems capable of predictive immunohistochemistry and in situ hybridisation testing, together with all the reagents, antibodies and consumables needed to run them, plus full risk maintenance. Zero tenders were received.Why This Contract MattersImmunohistochemistry is not a niche laboratory technique. It is one of the standard tools pathologists use to answer questions that directly shape cancer treatment decisions, for example, whether a breast tumour expresses the HER2 protein, a result that determines whether a patient is eligible for a specific class of targeted therapy. Predictive immunohistochemistry testing, the specific category covered by this lot, is precisely the kind of test result that changes what treatment a patient receives next.A public health authority unable to secure a supplier for this equipment category is not simply facing an administrative inconvenience. It faces a genuine risk to diagnostic capacity for cancer patients across its catchment area, unless existing equipment arrangements can be extended or the tender can be successfully relaunched with terms the market finds workable. That risk is precisely why a zero bid outcome in this specific equipment category deserves more scrutiny than a routine procurement delay would.Contract Timeline Date Milestone — Open procedure launched for a three year rental of immunohistochemistry and in situ hybridisation systems, split into two lots — Tender submission period closes with zero tenders received for Lot 1 20 July 2026Award notice dispatched to the EU Publications Office 21 July 2026 Notice published in OJ S 138/2026 Contract OverviewAzienda USL della Romagna ran an open procedure above EU thresholds to secure rental supply of automated systems for predictive and non predictive immunohistochemistry testing, in situ hybridisation and direct immuno fluorescence on histological and cytological preparations, bundled together with the reagents, antibodies, consumables and full risk technical assistance and maintenance the equipment requires to operate. The overall procurement, covering both lots, carried an estimated value of €21,736,400. Lot 1, the subject of this specific result, covered predictive immunohistochemistry and in situ hybridisation systems and carried an estimated value of €5,480,650.No tenders were received for Lot 1 by the submission deadline. The competition for this lot was formally closed with the explicit justification recorded in the notice: no tenders, requests to participate or projects were received at all.Key Contract Details Field Detail Contracting authority Azienda USL della Romagna Title P.A. Indagini Immunoistochimiche, Lot 1 CPV code 33696000 - Reagents and contrast media Procedure type Open Legal basis Directive 2014/24/EU Estimated value (full two lot procurement) €21,736,400 Estimated value of Lot 1 €5,480,650 Award criteria Most economically advantageous tender, Technical score: 70/100; Economic score: 30/100 Outcome No winner selected, no tenders received Tenders received 0 EU funding None disclosed GPA coverage No Framework agreement None, this is a direct supply/rental contract Review body TAR Emilia Romagna - Bologna Procurement service provider ANAC - Autorità Nazionale Anticorruzione Place of performance Ravenna, Italy Project ScopeLot 1 covers the three year rental of automated systems capable of running predictive immunohistochemistry tests, the category of testing used to determine whether specific biomarkers are present in a tumour sample, directly informing treatment eligibility decisions, alongside in situ hybridisation testing on histological and cytological preparations. The contract bundles in everything the equipment needs to function clinically: reagents, antibodies and general laboratory consumables, plus full risk maintenance and technical assistance, meaning the successful bidder would have carried ongoing responsibility for keeping the equipment operational throughout the contract term, not merely supplying it.The wider, two lot procurement's second lot, not covered in detail by this specific notice, addresses direct immuno fluorescence testing on the same category of tissue preparations, together, the two lots were intended to cover the full range of advanced tissue based diagnostic testing Azienda USL della Romagna's pathology laboratories require.About the Contracting AuthorityAzienda USL della Romagna is the regional public health authority serving the Romagna area of Emilia Romagna, including Ravenna, Forlì, Cesena and Rimini and operates as a body governed by public law under regional authority control. Its laboratory and pathology services support cancer diagnosis and treatment decisions across a substantial regional population, making reliable access to advanced diagnostic testing equipment, including the immunohistochemistry and in situ hybridisation systems covered by this lot, directly relevant to clinical cancer care capacity across the region.About the Organisations InvolvedNo supplier submitted a tender for this lot, so there is no winning organisation to profile and the notice does not identify any bidders who considered but ultimately declined to participate.TAR Emilia Romagna - Bologna, Review OrganisationThe Emilia Romagna Regional Administrative Court, based in Bologna, is the designated review body for this procurement, providing the formal legal channel through which any interested party could challenge procedural aspects of the tender, though the zero bid outcome itself is not, on its own, typically the kind of result subject to a formal legal challenge.ANAC - Autorità Nazionale Anticorruzione, Procurement Service ProviderItaly's National Anti Corruption Authority is named as the procurement service provider supporting this tender process, reflecting the additional procedural oversight ANAC frequently provides for complex or high value Italian public procurement, including healthcare equipment tenders of this kind.Procurement AnalysisA zero bid outcome in a specialised, seemingly attractive multi million euro equipment category is a genuinely unusual result and it is worth examining why it might occur even in a market served by several large, capable global suppliers of automated immunohistochemistry systems. Several structural possibilities are worth considering, though the notice itself does not disclose the market's reasoning.First, technical specifications drafted around a specific existing equipment platform, a common practice when a laboratory wants continuity with equipment its staff are already trained on, can inadvertently narrow eligibility so tightly that only one manufacturer's system could technically qualify and if that manufacturer chose not to bid for its own commercial reasons, no other supplier could credibly compete. Second, a three year rental term is comparatively short for this category of capital intensive diagnostic equipment; Italian public health rental agreements for advanced laboratory systems more commonly run five to seven years, allowing suppliers to amortise substantial equipment costs alongside the reagent and consumables supply that typically generates the bulk of contract revenue in these "full risk" service models. A shorter contract term can make the economics considerably less attractive for suppliers weighing the cost of installing and maintaining specialised equipment against a shorter revenue horizon.Third, the demanding 70% technical / 30% economic weighting, combined with full risk maintenance obligations bundled into a single rental contract, places substantial technical and financial risk on the winning bidder, a structure that, combined with a shorter contract term, may have made the overall economics of participating simply unattractive relative to the effort of preparing a compliant technical bid.Additional Procurement FactsNo tenders were received in any of the tracked categories: none submitted electronically, none from SMEs and none verified as inadmissible for any reason, since there was simply nothing submitted to evaluate. The lot carries no EU funding and is not covered by the WTO Government Procurement Agreement. No framework agreement or dynamic purchasing system was used for this procurement; it was structured as a conventional direct rental and supply contract.Market & Industry PerspectiveThe global market for automated immunohistochemistry and in situ hybridisation systems is served by a relatively small number of established manufacturers, companies including Roche (through its Ventana Medical Systems subsidiary), Agilent (through its Dako pathology solutions business), Leica Biosystems and Thermo Fisher Scientific, among others, each offering integrated platforms combining instrumentation, proprietary reagents and antibodies and service support. Public hospital laboratories across Europe frequently structure procurement for this category as bundled "full risk" rental contracts precisely because these systems require ongoing, specialised reagent supply and maintenance that is most efficiently sourced from a single accountable supplier rather than procured piecemeal.That this specific tender attracted no bids from any of these established suppliers suggests either a genuine and unusual, gap in market interest in the Romagna region specifically or, more plausibly, tender terms, whether technical specification, contract duration or risk allocation, that did not align with how these suppliers typically structure comparable rental agreements elsewhere in Italy and Europe.Economic SignificanceAt an estimated €5.48 million for this lot alone and €21.7 million across the full two lot procurement, this is a significant category of regional health spending left unresolved by the zero bid outcome. Beyond the direct financial figures, the economic and clinical stakes of an unfilled cancer diagnostics equipment contract compound over time: laboratories without a secured long term rental arrangement may face pressure to extend existing, potentially ageing equipment contracts on less favourable terms or absorb the administrative and clinical disruption of running a second competitive procurement process before resolving their equipment needs.Future Procurement OpportunitiesAzienda USL della Romagna will most likely need to relaunch this lot and the standard response to a zero bid outcome in Italian public procurement is typically a negotiated procedure without prior publication, inviting known market suppliers directly or a revised open tender with adjusted technical specifications, contract duration or risk sharing terms designed to draw genuine market interest. Suppliers of immunohistochemistry and in situ hybridisation systems should watch for a relaunched competition from this same authority, likely on revised terms more closely aligned with standard market practice for equipment of this kind.Opportunities for SuppliersFor manufacturers of automated immunohistochemistry systems, this notice is a live signal of unmet demand in a specific Italian regional market. Any supplier able to meet Azienda USL della Romagna's clinical requirements and willing to engage with the authority directly on contract terms, has a clear opening to shape the specification of a relaunched tender, a genuine advantage over waiting for a subsequent open competition to appear on the same terms that failed to attract bids the first time.What Businesses Should WatchThree things are worth tracking following this zero bid result. First, whether Azienda USL della Romagna revises the contract's duration or risk sharing structure before relaunching the tender, since either change would signal the authority's own diagnosis of why the original terms failed to attract bidders. Second, whether the authority pursues a negotiated procedure directly with known suppliers rather than a further open competition, a common and faster route to resolving a zero bid outcome for essential clinical equipment. Third, how Lot 2 of the same procurement, covering direct immuno fluorescence testing, ultimately fared, since a parallel zero bid or low participation result there would suggest a more systemic issue with how the overall two lot tender was structured, rather than an issue specific to Lot 1 alone.ItalyTenders.com Procurement IntelligenceA zero bid outcome on a multi million euro equipment tender is one of the more informative "non events" a procurement notice can record, precisely because it is rare enough to demand an explanation the notice itself does not provide. Unlike a cancelled tender following bids that exceeded budget or a single bidder result reflecting a genuinely narrow supplier market, a complete absence of tenders in a category served by several large, well capitalised global manufacturers points toward a mismatch between what the buyer specified and what the market was prepared to offer under those specific terms.For public health authorities designing similarly bundled, full risk rental contracts for specialised diagnostic equipment, this result is worth treating as a cautionary data point: contract duration, risk allocation and the balance between technical specificity and genuine multi supplier eligibility all meaningfully affect whether a tender draws bids at all, not just how competitively it is priced. A specification narrow enough to exclude every credible supplier from bidding produces exactly this outcome, a technically valid, EU compliant tender that nonetheless fails at the most basic level, attracting no market response whatsoever.For suppliers, the lesson runs the other way: a well publicised zero bid result is a rare, low competition opportunity to engage directly with a public buyer that has already demonstrated genuine, unmet demand for exactly the equipment category a manufacturer sells, a considerably stronger negotiating position than responding to a fresh, untested open tender.Supplier Takeaways A zero bid outcome on essential clinical equipment strongly signals unmet demand and an unusually favourable negotiating position for any supplier prepared to engage the authority directly on relaunching the tender. Contract duration matters as much as headline value in capital intensive diagnostic equipment rentals; a three year term may be too short to make full risk maintenance and reagent supply economically attractive compared with the five to seven year terms more common in this category. Overly specific technical requirements, potentially modelled on a single incumbent platform, can inadvertently exclude the broader supplier market from bidding at all. Watch for Azienda USL della Romagna to relaunch this lot via a negotiated procedure or revised open tender, likely on adjusted terms. Track the outcome of the procurement's second lot (direct immuno fluorescence systems) for signs of whether this is an isolated result or part of a broader structural issue with the overall tender design. Key Takeaways Azienda USL della Romagna's tender for a three year rental of predictive immunohistochemistry and in situ hybridisation systems, estimated at €5.48 million, received zero tenders and was closed without a winner. The lot forms part of a wider €21.7 million, two lot procurement covering advanced tissue based cancer diagnostic testing equipment. The contract bundled equipment rental with reagents, antibodies, consumables and full risk maintenance, a demanding, high risk structure for bidders. No EU funding was involved and the contract is not covered by the WTO Government Procurement Agreement. The authority is likely to relaunch the tender, potentially via a negotiated procedure or with revised technical and contractual terms. Conclusion Empty result fields in a procurement notice rarely make for dramatic reading, but this one is worth pausing over. A public health authority went to market for equipment that helps determine cancer treatment decisions for its patients and not a single supplier in a global market stocked with capable manufacturers chose to respond. That silence says more about how the tender was built than about the underlying demand and it leaves Azienda USL della Romagna with a genuine, unresolved gap in its diagnostic equipment pipeline until a revised competition succeeds where this one did not. Source: EU Official Journal, Contract Award Notice 501991-2026, OJ S 138/2026, published 21/07/2026. Contracting authority: Azienda USL della Romagna.
View Details
Rome's Oldest Public Hospital Turns to Private Capital to Rebuild a 19th Century Laboratory Block Into a Modern Health Hub
20 Jul 2026
StandfirstPoliclinico Umberto I, the Roman teaching hospital that has treated patients since 1883, has awarded a public private partnership concession to rebuild and run "Building 28", currently home to ageing laboratories and its transfusion centre, as a new multi speciality healthcare facility. The winning partnership, led by medical technology group Althea Italia alongside smaller partner Beoncare, will also run telemedicine and home care services and maintain the equipment it installs, under a concession estimated at close to €79 million.IntroductionSome of Europe's grandest teaching hospitals carry the weight of their own history in the buildings themselves. Policlinico Umberto I, opened in Rome in 1904 and named for the Italian king who presided over its inauguration, remains one of the country's largest public hospitals, and, like many institutions of its age, it is now confronting the practical reality that a 19th century campus was never designed for 21st century diagnostics, telemedicine or home based patient care.Building 28, currently used as laboratory space and the hospital's transfusion centre, is the latest part of that campus to be redeveloped, but through a financing route Italian public hospitals increasingly favour when capital budgets are tight: a project finance concession, awarding a private partner the right and responsibility to design, build, equip and run a facility in exchange for a long term service and management contract, rather than the hospital funding construction directly from its own budget. Policlinico Umberto I has now concluded that concession, awarding it to a partnership led by Althea Italia S.p.A. alongside Beoncare S.r.l.Why This Contract MattersPublic hospitals across Europe face the same structural tension: patient care and clinical staffing budgets compete directly with the capital needed to modernise buildings, equipment and digital infrastructure. Project finance concessions, where a private operator funds construction upfront and recovers its investment over years or decades of service delivery, have become one of the standard tools Italian public health bodies use to break that deadlock, particularly for large teaching hospitals with extensive but ageing physical estates.This concession is also notable for what it bundles together. Rather than procuring construction, facility management, telemedicine and equipment maintenance as separate contracts, Policlinico Umberto I combined them into a single, long term partnership, a structure that shifts not just construction risk but ongoing operational and technology risk onto the private partner, in exchange for a correspondingly long term revenue relationship.Contract Timeline Date Milestone — Open telematic procedure launched under Article 71 of Italian Legislative Decree 36/2023 26 September 2025 Winner selected 19 December 2025 Contract concluded with RTI Althea Italia S.p.A.-Beoncare S.r.l. 16 July 2026 Award notice dispatched to the EU Publications Office 20 July 2026 Notice published in OJ S 137/2026 Contract OverviewPoliclinico Umberto I ran an open telematic (fully electronic) procedure under Article 71 of Italy's public contracts code (Legislative Decree 36/2023), structured as a project finance concession under Article 193 of the same code, a mechanism that allows a private operator to finance, build and operate public infrastructure in exchange for a concession to manage and profit from the resulting facility over an agreed term. The scope covers construction of a new multi specialty healthcare facility within Building 28, together with ongoing management of the facility, a telemedicine and home care assistance service and maintenance of the equipment supplied.Only one tender was received. RTI Althea Italia S.p.A.-Beoncare S.r.l., a temporary business partnership led by Althea Italia as lead contractor, alongside smaller Rome based partner Beoncare, was declared the winner. The tender was evaluated using Italy's "offerta economicamente più vantaggiosa" (most economically advantageous tender) methodology, weighted 70% on technical merit and 30% on economic terms.Key Contract Details Field Detail Contracting authority Policlinico Umberto I Winning partnership RTI Althea Italia S.p.A. (lead)X-rayBeoncare S.r.l. Title PPP Struttura Sanitaria Polispecialistica Ed. 28 CPV code 50421200-Repair and maintenance services of X-ray equipment Procedure type Open, telematic (electronic), project finance concession Legal basis Directive 2014/23/EU (Concessions Directive); Italian Legislative Decree 36/2023, Articles 71 and 193 Estimated value (excl. VAT) €78,795,520.45 Value of the winning tender €17,414,650.48 Total value of contracts awarded in this notice €17,502,161.29 Award criteria Most economically advantageous tender, Technical score: 70/100; Economic score: 30/100 Estimated revenue from concession users €0.00 (as recorded in the notice) Estimated revenue from the granting authority €0.00 (as recorded in the notice) Tenders received 1, submitted electronically EU funding None disclosed GPA coverage No Subcontracting Not yet known at the time of the notice Review body TAR Regione Lazio-Roma (Regional Administrative Court of Lazio) Procurement service provider ANAC-Autorità Nazionale Anticorruzione (National Anti-Corruption Authority) Place of performance Roma, Italy Project ScopeThe concession covers the construction of a new multi specialty healthcare facility ("struttura sanitaria polispecialistica") within Building 28 of the Policlinico Umberto I campus, an area currently occupied by hospital laboratories and the transfusion centre, as part of the hospital's wider, longer running reorganisation and refurbishment programme covering several campus buildings. Beyond construction, the winning partnership is responsible for ongoing management of the facility, delivery of telemedicine and home based patient assistance services and maintenance of the medical equipment installed as part of the project.The CPV classification recorded against this contract, "repair and maintenance services of X-ray equipment", is notably narrower than the full scope described in the notice's own text, which spans construction, facility management, telemedicine and home care alongside equipment maintenance. This is likely a limitation of how the notice was classified for publication rather than an indication that equipment maintenance is the concession's primary focus; readers should treat the broader project description, rather than the single CPV code, as the more accurate guide to the contract's actual scope.About the Contracting AuthorityPoliclinico Umberto I is one of Italy's largest and oldest public teaching hospitals, opened in Rome in 1904 and affiliated with Sapienza University of Rome. Structured as a body governed by public law under regional authority control and operating within the health sector, the hospital runs a broad range of specialist clinical departments, research centres and teaching functions across a large, multi building campus in the city's university district. Like many hospitals of comparable age, its physical estate includes a mix of modern facilities and older buildings originally designed for very different clinical needs than those it serves today, a gap this concession is intended to help close for Building 28 specifically.About the Organisations InvolvedALTHEA ITALIA S.P.A., Winning Tenderer (Lead Partner)Althea Italia is the Italian arm of Althea Group, an international provider of medical equipment management and technology services to hospitals, working across equipment maintenance, procurement support and increasingly, broader facility and clinical technology management for healthcare providers. Notably, Althea already maintains an existing institutional relationship with Policlinico Umberto I, appearing in the hospital's own published organisational information, suggesting this concession builds on, rather than establishes, a working relationship between the two organisations. As lead partner of the winning consortium, Althea brings the medical technology and equipment management expertise central to the concession's ongoing maintenance obligations.Beoncare S.r.l., Winning Tenderer (Consortium Partner)Beoncare, based in Rome and classified as a micro, small or medium sized enterprise, joins Althea Italia as the smaller partner in the winning consortium. Its specific role within the partnership is not detailed in the notice, though its inclusion alongside a larger, internationally established medical technology group is consistent with a common pattern in Italian project finance concessions, where a large lead partner brings scale and financing capacity while a smaller, more specialised local partner contributes complementary services, potentially in this case around the telemedicine or home care service components of the contract.TAR Regione Lazio-Roma, Review OrganisationThe Regional Administrative Court of Lazio, based in Rome, is Italy's designated venue for legal challenges against public administrative decisions, including procurement and concession awards, in the Lazio region. Its role here is limited to providing the formal legal channel through which any interested party could contest the award.ANAC-Autorità Nazionale Anticorruzione, Procurement Service ProviderItaly's National Anti Corruption Authority is named in the notice as the procurement service provider supporting this concession process. ANAC's core mandate covers anti corruption oversight and integrity monitoring across Italian public administration and its role in supporting complex procurement procedures, particularly high value concessions and project finance arrangements, reflects the additional scrutiny and procedural support Italian authorities often apply to this category of public private partnership.Procurement AnalysisThe choice of a project finance concession under Article 193 of Italy's public contracts code, rather than a conventional works and services contract, reflects a well established Italian public health sector approach to funding capital intensive hospital modernisation without drawing directly on public capital budgets. Under this model, the private partner, here, the Althea led consortium, takes on the financing and delivery risk for construction and recovers its investment through the long term management and service revenues the concession generates.That only a single tender was received is a notable feature of this competition. While not unusual for large, complex project finance concessions, which often require substantial upfront technical and financial capability that narrows the realistic bidder pool considerably, it does mean the award was effectively a negotiation over the terms of a single qualifying proposal rather than a competitive selection among multiple credible bids. The 70/30 technical to economic weighting reinforces that the hospital prioritised the quality and credibility of the proposed technical and service solution over the financial terms alone, consistent with how Italian authorities typically structure evaluation for concessions of this complexity.Additional Procurement FactsThe single tender received was submitted electronically and no tenders were recorded as inadmissible or as involving abnormally low pricing, since only the one qualifying tender was submitted. Subcontracting arrangements for the winning consortium are listed as "not yet known" at the time of the notice's publication. The project carries no EU funding and is not covered by the WTO Government Procurement Agreement, meaning it is financed and delivered entirely through the concession structure agreed between the hospital and the winning consortium.Market & Industry PerspectiveHealthcare project finance concessions of this kind sit at the intersection of construction, facilities management and medical technology services, a combination that favours bidders like Althea Group, whose core business already spans hospital equipment management and increasingly broader clinical technology and facility services across multiple countries. The relatively narrow field of credible bidders for a concession of this scale and complexity reflects the genuine difficulty of assembling a consortium with construction financing capability, medical equipment expertise and long term facility and service management experience all under one proposal.Italian public hospitals have increasingly turned to this concession model for campus modernisation projects precisely because it allows large, historically significant but ageing institutions, like Policlinico Umberto I, whose main buildings predate modern digital and diagnostic infrastructure by well over a century, to redevelop specific buildings incrementally, without requiring the kind of large single capital outlay that would otherwise compete directly against clinical budgets.Economic SignificanceAt an estimated value of €78.8 million, this is a substantial concession for a single hospital building redevelopment, reflecting both the construction investment required and the long term service revenue built into the arrangement. The distinctly smaller figure recorded against the winning tender itself, €17.4 million, likely reflects a specific, more narrowly defined component of the overall concession value rather than the full economic scope of the arrangement, though the notice does not clarify precisely how these two figures relate to one another.For Althea Italia and Beoncare, the win extends an existing institutional relationship with one of Rome's largest public hospitals into a substantially larger, longer term concession covering construction, facility management and clinical technology services, a meaningful expansion of scope compared with a conventional equipment maintenance contract alone.Future Procurement OpportunitiesGiven that Building 28 is only one part of Policlinico Umberto I's wider, longer running campus reorganisation and refurbishment programme, which has separately encompassed buildings housing ophthalmology, obstetrics and gynaecology, surgical clinics and central radiology, further concessions or works contracts addressing other ageing buildings across the same campus are a reasonable expectation over the coming years, following whatever pattern of financing and delivery this Building 28 concession establishes as a working template.Suppliers of medical imaging and diagnostic equipment, telemedicine platforms and home care service technology should also watch for procurement activity tied to the operational phase of this concession as the new facility moves from construction into service delivery.Opportunities for SuppliersFirms specialising in telemedicine platforms, remote patient monitoring and home care service delivery technology may find subcontracting or partnership opportunities beneath the Althea Beoncare consortium as the facility's telemedicine and home care components move into implementation, particularly given that subcontracting arrangements remain undisclosed at this stage. Medical equipment suppliers and specialist construction firms with hospital sector experience should also watch for adjacent opportunities as Policlinico Umberto I's wider campus reorganisation programme continues to unfold across its other ageing buildings.What Businesses Should WatchThree things are worth tracking as this concession moves forward. First, how Policlinico Umberto I structures any further redevelopment concessions for other buildings in its ongoing campus reorganisation programme, given the precedent this Building 28 award sets for both procedure and consortium structure. Second, how the telemedicine and home care service components of the concession are implemented in practice, since these represent a meaningfully different scope from the traditional construction and maintenance concessions more commonly seen in Italian hospital procurement. Third, whether the apparent gap in disclosed revenue information for this concession is clarified in subsequent contract documentation or future related notices, since that detail matters directly to understanding how the concession is actually financed and repaid over its term.ItalyTenders.com Procurement IntelligenceThis concession illustrates a durable pattern in how Europe's oldest public hospitals are modernising piece by piece, building by building, using private capital and long term service concessions rather than waiting for centralised public capital budgets to fund wholesale campus reconstruction. Policlinico Umberto I's approach, treating Building 28 as a self contained project finance concession bundling construction, facility management, telemedicine and equipment maintenance into a single long term partnership, is a genuinely instructive model for other large, historically significant public hospitals facing the same structural challenge: valuable, irreplaceable institutional history housed in buildings that predate modern clinical technology by a century or more.The fact that only one qualifying tender was received is worth sitting with rather than glossing over. Complex healthcare project finance concessions of this scale inherently narrow the field of credible bidders to a small handful of organisations capable of combining construction financing, medical technology expertise and long term facility management under one proposal, and in this case, that field narrowed to exactly one. That is not necessarily a sign of a flawed procurement process, but it is a reminder that genuine competitive tension in this specific category of public private partnership is often thinner than the headline contract value might suggest and public buyers considering similar concessions should weight their evaluation criteria, as Policlinico Umberto I did, at 70% technical and 30% economic, accordingly, prioritising the credibility and quality of whatever proposal does emerge over price competition that a single bidder field cannot meaningfully generate.Looking ahead, the bundling of telemedicine and home care services directly into a hospital construction concession, rather than procuring them as separate, subsequent contracts, is itself a signal worth watching. As European public hospitals increasingly extend care beyond their own physical walls into patients' homes, expect more capital redevelopment concessions to fold digital and remote care service delivery into the same long term partnership from the outset, rather than treating them as an afterthought once new physical infrastructure is complete.Supplier Takeaways Italian public hospitals continue to favour project finance concessions under Article 193 of the national procurement code for capital intensive campus modernisation, particularly for historically significant institutions with ageing physical estates. Complex healthcare concessions bundling construction, facility management, telemedicine and equipment maintenance narrow the credible bidder field considerably, genuine competitive tension may be limited even in high value competitions. Existing institutional relationships with a hospital (as Althea Italia had with Policlinico Umberto I) appear to be a meaningful advantage when competing for bundled concessions of this kind. Subcontracting opportunities in telemedicine, remote monitoring and home care technology are worth pursuing beneath large lead consortia, particularly where subcontracting status remains undisclosed at award. Watch for further concessions tied to Policlinico Umberto I's wider, multi building campus reorganisation programme, which has already addressed several other ageing buildings across the site. Key Takeaways Policlinico Umberto I awarded a project finance concession, estimated at €78.8 million, to a consortium led by Althea Italia S.p.A. alongside Beoncare S.r.l., to redevelop Building 28 into a multi specialty healthcare facility. The concession bundles construction, facility management, telemedicine, home care assistance and equipment maintenance into a single long term partnership. Only one tender was received for the competition, evaluated on a 70% technical, 30% economic basis. The contract carries no EU funding and is not covered by the WTO Government Procurement Agreement. ConclusionA hospital that has treated Roman patients since before the First World War is not an institution that modernises quickly or cheaply and this concession is a pragmatic response to that reality: rebuild what needs rebuilding, one building at a time, using private capital and a long term service partnership rather than waiting for public budgets to catch up with clinical need. For Althea Italia and Beoncare, it is a meaningful expansion of an existing relationship into a substantially larger, longer commitment. For Policlinico Umberto I, it is one more piece of a very old campus quietly being brought into the present.Source: EU Official Journal, Contract Award Notice 498574-2026, OJ S 137/2026, published 20/07/2026. Contracting authority: Policlinico Umberto I.
View Details
Chiari’s 31-year cremation project closes without a bidder, leaving a larger question for Italy’s local infrastructure market
17 Jul 2026
Introduction: The planned public private partnership in Chiari, near Brescia, was meant to bring together construction, design and long term operations for a thermal treatment centre for human remains. Instead, the tender closed with no bids, turning this award notice into a signal about procurement appetite, project design and market risk rather than a contract win. The Comune di Chiari had sought a 31 year concession style arrangement under Directive 2014/23/EU, with an estimated value of €115.1 million excluding VAT. But the buyer ultimately cancelled the competition after its needs changed and no winner was selected. Why this contract matters This was not a routine municipal service contract. It combined executive design, works and long term management of a specialised facility, which means the public sector was trying to solve both an infrastructure gap and an operating challenge through a single procurement vehicle. For local authorities, this kind of model is attractive because it can shift delivery risk, attract private capital and lock in a long service horizon. For suppliers, it would have created a rare opening in a niche market that sits at the intersection of cemetery services, public works and concession finance. The fact that the process ended with zero tenders is itself instructive. It suggests the project structure, commercial terms or demand assumptions may not have matched market expectations strongly enough to bring bidders in. Contract timeline The notice records a previous publication under reference 390719-2026, indicating that the market had already seen an earlier stage of the procedure. The result notice was dispatched on 16 July 2026 and published in the Official Journal on 17 July 2026. The contracting authority then closed the competition without selecting a winner, citing a change in needs. No bids were received. Contract overview The project covered the executive design, construction and management of a multifunctional thermal treatment centre for human remains in Chiari, in the province of Brescia. In plain terms, this would have been a facility for cremation related and related thermal treatment services, operated over a 31 year term. The contract was structured as a public private partnership through project financing, a model typically used when the public sector wants the private side to help fund and deliver infrastructure while also taking on part of the operating responsibility. The notice classifies the contract as services with an additional works component. Key contract details BuyerComune di Chiari (BS) ProcedurePublic private partnership through project finance Legal basisDirective 2014/23/EU CPV98371100 – Cemetery services and cremation services Estimated value€115,127,694 excluding VAT Duration31 years Lot structureSingle lot, LOT 0001 Award outcomeNo winner selected; competition closed Tenders received0 EU fundsNot financed with EU funds GPA statusNot covered by the Government Procurement Agreement Project scope The scope was unusually broad for a municipal service procurement. It was designed to cover the full lifecycle: executive design, works delivery and long term management of the facility. That matters because bidders would have needed capabilities across civil works, facility operations, compliance, technical design and long term asset management. In other words, this was not a simple construction tender but an integrated concession style investment proposition. The absence of bids indicates the market did not step in, at least under the terms offered. That can happen when traffic or utilisation assumptions are weak, financing becomes expensive or the private partner sees too much long dated operational risk. About the contracting authority Comune di Chiari (BS) is the local authority acting as buyer for this procurement. The municipality is responsible for general public services and it also provided offline access to the procurement documents. Its involvement suggests the project was intended to respond to a local public service need in Brescia province. The notice does not explain the underlying service gap in detail, but the size and duration of the planned facility show that the municipality was seeking a structural rather than short term solution. About the organisations involved Comune di Chiari (BS): Role: Buyer and document provider. What it does: Comune di Chiari is the local municipal authority in Chiari, Brescia, responsible for local public services. Why it matters: It initiated and then closed the procurement after deciding its needs had changed, making it the key decision maker in the process. Centrale Unica di Committenza Area Vasta Brescia Provincia di Brescia: Role: Organisation providing additional information about the procurement procedure. What it does: This is the central purchasing body serving the Brescia area, housed within the Province of Brescia. Why it matters: Its presence shows the procurement was handled through a centralised support structure, which often helps municipalities manage complex tenders more efficiently. TAR Tribunale Amministrativo Regionale sezione di Brescia: Role: Review organisation and body for further review information. What it does: TAR Brescia is the regional administrative court that hears procurement and administrative disputes in the area. Why it matters: It is the formal avenue for legal challenge, which is relevant in concession and public private partnership procedures where commercial stakes can be high. Procurement analysis This procurement was run under the concession framework of Directive 2014/23/EU, which is typically used when the private sector will operate a service and bear meaningful demand or operational risk. That choice is important because it tells bidders the authority was not simply buying a building; it was seeking a long term delivery model. The competition level was effectively nil. No tenders or participation requests were received and the process ended with no award. That outcome points to one of three common issues: the project may have been too complex, the commercial case may have been too weak or the authority may have changed direction before the market could respond. The notice does not disclose more, so the contracting authority has not disclosed this information. Additional procurement facts The contract was a single lot procurement, so there were no separate geographic or functional awards to split across different suppliers. The notice says the project was not financed with EU funds and was not covered by the GPA, which means the procurement sat outside some of the wider international funding and access dynamics that can sometimes broaden bidder participation. The award criterion was quality based, with further details referenced in the tender documents, but the notice does not publish the scoring formula. The contracting authority has not disclosed this information. Market and industry perspective For the cremation and cemetery services market, this notice is a reminder that demand is increasingly being packaged into infrastructure style contracts rather than standalone service arrangements. That raises the bar for suppliers, because they must now think like operators, developers and financiers at the same time. For construction firms, the opportunity lies in niche public assets where the public sector wants speed and lifecycle certainty. For operators, the bigger prize is long duration revenue in a local monopoly style service, but only if the project economics are credible. The zero bid outcome suggests caution in the market. Suppliers may see future opportunities here, but only if authorities make the revenue model, service scope and risk allocation more bankable. Economic significance A €115.1 million project of this type would have represented a significant local investment for Chiari and the surrounding Brescia area. Even though no award followed, the scale of the contemplated project shows how municipal procurement can influence local construction activity, specialised service capacity and long term employment. Projects like this also affect capital allocation in small and mid sized Italian markets. When they are structured well, they can draw private investment into public infrastructure; when they are not, they can stall and delay service improvement. Future procurement opportunities The cancellation leaves open the possibility of a redesigned tender, a revised concession structure or a different delivery model. The notice does not specify next steps, so the contracting authority has not disclosed this information. Future opportunities are likely to focus on suppliers with experience in concession finance, local public works and long term facility management. If the project returns, the market will watch for changes in risk allocation, duration, pricing and demand assumptions. Opportunities for suppliers Suppliers should treat this as a signal to build capability across several disciplines rather than bidding as a single skill contractor. The strongest contenders in future rounds are likely to be those that can combine design, delivery, operations and financing. There may also be openings for specialist subcontractors in technical systems, facility engineering, maintenance and compliance services. The notice does not identify subcontractors or partners, so the contracting authority has not disclosed this information. What businesses should watch Businesses should monitor whether Chiari reissues the project with a lower risk profile or a narrower scope. A second attempt would be an important signal about how Italian local authorities are adjusting PPP structures in sensitive municipal service markets. They should also watch for similar projects in other provinces. When one local authority tests a concession model and the market does not respond, others often revise their own plans before launching comparable tenders. ItalyTenders.com Procurement Intelligence This notice points to a broader procurement trend: municipalities are still trying to use public private partnerships for specialised social infrastructure, but the market will only engage when the economics are clear and the risks are believable. Strategically, the case matters because it shows that long duration concessions are not automatically attractive, even where the service need is real. Suppliers should respond by demanding clearer revenue assumptions, more balanced risk sharing and a structure that matches long term operating realities. In future, contracts of this kind may evolve toward more modular scopes, stronger pre tender market sounding and better defined service outputs. That would make them easier to finance and more attractive to bidders, especially in specialised municipal assets where demand is local and politically sensitive. Supplier takeaways Build bidding capability for PPP and concession models, not just construction work. Assess long term operational risk before pricing a project of this type. Watch for retendering after a change in municipal needs. Track Brescia and broader Lombardy local authority procurement for similar niche infrastructure opportunities. Prepare partnerships with operators, engineers and financiers if the project returns. Key takeaways Chiari sought a 31 year PPP for a multifunctional thermal treatment centre for human remains. The estimated value was €115.1 million excluding VAT. No tenders were received and no winner was chosen. The buyer cancelled the competition because its needs changed. The case highlights the importance of commercial design in concession procurement. Conclusion What looked like a straightforward award notice is really a market signal about the limits of PPP appetite in specialised municipal services. The project may return in a revised form, but for now the more important story is that the market did not buy into the proposition as presented. For suppliers, the message is clear: future success will depend less on generic construction capacity and more on the ability to package finance, operations and long term risk into a credible offer. Frequently asked questions What was the procurement about? It was a 31 year public private partnership for the executive design, construction and management of a thermal treatment centre for human remains in Chiari, Italy. Who was the buyer? The buyer was Comune di Chiari (BS). Was a contract awarded? No. The competition closed without a winner and no tenders were received. Why was there no award? The buyer decided not to proceed because its needs changed. What is the value of the project? The estimated value was €115,127,694 excluding VAT.Source: TED Contract Award Notice 494310-2026, OJ S 136/2026, published 17 July 2026. Disclaimer: This article is based on the notice text provided and should be read as procurement intelligence, not legal advice.
View Details